Evidence map›Paper›PMID 25630949›Full record

ArticleGene therapy2015

Chimeric rabies SADB19-VSVg-pseudotyped lentiviral vectors mediate long-range retrograde transduction from the mouse spinal cord.

L Schoderboeck, S Riad, A M Bokor, H E Wicky, M Strauss, M Bostina, M J Oswald, R M Empson, S M Hughes

Abstract read
PubMed Publisher
In one paragraph

Article in Gene therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

L Schoderboeck1] Department of Biochemistry, University of Otago, Dunedin, New Zealand [2] Brain Health Research Centre, University of Otago, Dunedin, New Zealand.
S RiadDepartment of Biochemistry, University of Otago, Dunedin, New Zealand.
A M BokorDepartment of Biochemistry, University of Otago, Dunedin, New Zealand.
H E Wicky1] Department of Biochemistry, University of Otago, Dunedin, New Zealand [2] Brain Health Research Centre, University of Otago, Dunedin, New Zealand.
M Strauss1] Otago Centre for Electron Microscopy, University of Otago, Dunedin, New Zealand [2] Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
M Bostina1] Otago Centre for Electron Microscopy, University of Otago, Dunedin, New Zealand [2] Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
M J Oswald1] Brain Health Research Centre, University of Otago, Dunedin, New Zealand [2] Department of Physiology, Otago School of Medical Sciences, University of Otago, Dunedin, New Zealand.
R M Empson1] Brain Health Research Centre, University of Otago, Dunedin, New Zealand [2] Department of Physiology, Otago School of Medical Sciences, University of Otago, Dunedin, New Zealand.
S M Hughes1] Department of Biochemistry, University of Otago, Dunedin, New Zealand [2] Brain Health Research Centre, University of Otago, Dunedin, New Zealand [3] Genetics Otago, University of Otago, Dunedin, New Zealand.
University of Otago · NZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lentiviral vectors have proved an effective method to deliver transgenes into the brain; however, they are often hampered by a lack of spread from the site of injection. Modifying the viral envelope with a portion of a rabies envelope glycoprotein can enhance spread in the brain by using long-range axon projections to facilitate retrograde transport. In this study, we generated two chimeric envelopes containing the extra-virion and transmembrane domain of rabies SADB19 or CVS-N2c with the intra-virion domain of vesicular stomatitis virus. Viral particles were packaged containing a green fluorescent protein reporter construct under the control of the phosphoglycerokinase promoter. Both vectors produced high-titer particles with successful integration of the glycoproteins into the particle envelope and significant transduction of neurons in vitro. Injection of the SADB19 chimeric viral vector into the lumbar spinal cord of adult mice mediated a strong preference for gene transfer to local neurons and axonal terminals, with retrograde transport to neurons in the brainstem, hypothalamus and cerebral cortex. Development of this vector provides a useful means to reliably target select populations of neurons by retrograde targeting.

Indexed as

Axonal TransportGene Transfer TechniquesAnimalsCells, CulturedGenetic VectorsGlycerol KinaseGreen Fluorescent ProteinsLentivirusMiceMice, Inbred C57BLNeuronsPromoter Regions, GeneticRabies virusRecombinant ProteinsSpinal CordVesiculovirusGlycerol KinaseGreen Fluorescent ProteinsRecombinant ProteinsViral Envelope Proteins

Identifiers

PMID25630949
OpenAlexW2016372424

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.